Pricing Log in Create free account

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR (CUVL) vs Larimar Therapeutics, Inc. (LRMR)

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and Larimar Therapeutics, Inc. are both Biotechnology companies. Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and Larimar Therapeutics, Inc. are of similar size ($257.5M and $248.3M).

Valuation

Metric CUVL LRMR Biotechnology median
P/E — n/m 10.60
P/S — n/m 9.40
P/B — 1.95 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — n/m 9.02
Earnings yield — (81.59%) (32.88%)
Free cash flow yield — (62.87%) (23.13%)

Profitability

Metric CUVL LRMR Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — (138.41%) (51.96%)
Return on assets — (108.53%) (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric CUVL LRMR Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) — (71.97%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CUVL LRMR Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 4.70 4.97
Net debt to EBITDA — 0.79 1.01

Dividend

Metric CUVL LRMR Biotechnology median
Dividend yield 0.56% — 0.41%
Payout ratio — — —

Size

Metric CUVL LRMR Biotechnology median
Market cap 257.50m 248.28m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack